FdaApplication

NDA 021281

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS NORTH AMERICA INC
application_typeNDA
approval_date2001-05-03

Products (2)

ProductActive ingredientStrengthDosage form
PREVACIDLANSOPRAZOLE15MG/PACKETFOR SUSPENSION, DELAYED RELEASE;ORAL
PREVACIDLANSOPRAZOLE30MG/PACKETFOR SUSPENSION, DELAYED RELEASE;ORAL

2 products